Melanoma

• FDA label_change · 2021-12-03
  FDA Approved: MEKINIST — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for MEKINIST (trametinib) from Novartis Pharmaceuticals Corporation. This action updates the dru…

• FDA label_change · 2012-02-16
  FDA Approved: YERVOY — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  FDA announces a supplemental application for YERVOY (ipilimumab) submitted by E.R. Squibb & Sons, L.L.C., relating to labeling changes for t…